The increased in vivo resistance to wear of highly crosslinked polyethylene (HXLPE) in total hip arthroplasty (THA) has led to an increased use of larger articulations which have been shown to reduce the incidence of early dislocation. To date, there are few reports of the wear of larger articulations using second generation HXLPE liners. Our prospective cohort study measured the bedding-in and early wear of large (36 mm and 40 mm diameter) articulations involving a second generation X3 HXLPE liner and compared our findings with previous clinical and in vitro studies of the same material.
1
The use of larger articulations has long been known to increase the stability of the joint by increasing the distance required for the femoral head to disengage from the acetabular component. 2, 3 A large multi-centre randomised controlled trial found that the incidence of dislocation one year after primary THA was significantly lower in those with a femoral head whose diameter was 36 mm (0.8%) than in those with a diameter of 28 mm articulation (4.4%, p = 0.024). 4 Cohort studies have also found a decreased risk of revision THA for dislocation or instability when larger articulations were used. [5] [6] [7] [8] However, when used in conjunction with conventional ultra-high molecular weight polyethylene (UHMWPE), larger articulations had increased rates of wear. [9] [10] [11] The introduction of highly crosslinked polyethylene (HXLPE) acetabular components in the late 1990s as a result of laboratory studies 12 has resulted in decreased rates of wear. [13] [14] [15] [16] Consequently the use of larger articulations in primary THA has increased during the last ten years. 1 Second generation HXLPE liners are manufactured using a different sequence of treatments in an attempt to further reduce the production of free radicals. 17 One type of second generation HXLPE liner (X3, Stryker Orthopaedics, Mahwah, New Jersey), manufactured with sequential irradiation and annealing, showed significantly reduced gravimetric wear in vitro when used in a standardsized articulation compared with conventional polyethylene. 18 However, in the same study, the use of larger articulations with an X3 liner significantly increased the amount of gravimetric wear (p = 0.013). 18 A second in vitro study of the same liner with a 36 mm femoral head found that decreasing its thickness increased the rate of wear. 19 The low amount of wear measured in these studies is difficult to quantify accurately in vivo. Radiostereometric analysis (RSA) is acknowledged as the most precise method of measuring the rate of wear of polyethylene in vivo. [20] [21] [22] We have previously used RSA to show that the rate of wear of a second generation HXLPE liner is very low when used with a 32 mm metal femoral head at two 23 and five years. 24 Hence, the aim of the current study was to measure the bedding-in and early rates of wear of the second generation HXLPE liner when used with 36 mm or 40 mm articulations.
Patients and Methods
This prospective cohort study involved 19 consecutive patients who underwent primary THA with a 36 mm or 40 mm femoral head between May 2007 and January 2009 by a single surgeon (DGC). The need to use an acetabular component with an outer diameter of < 52 mm was an intra-operative exclusion criterion due to this resulting in a thickness of liner of < 5.8 mm with a 36 mm articulation. This cohort was compared with a previous consecutive cohort of 21 patients who underwent THA between September 2005 and July 2006 involving a 32 mm articulation and the same HXLPE liner. All THAs were undertaken by the same surgeon (DGC) at Wakefield Hospital. For both cohorts, patients were eligible for inclusion if they had a diagnosis of osteoarthritis; were aged between 45 and 80 years; were deemed suitable for an uncemented THA; and resided within the Adelaide metropolitan area. 23, 24 Ethical approval was obtained and the trial was registered with the Australian New Zealand Clinical Trials Registry (#ACTRN12616000952448).
All patients in both cohorts received a second generation HXLPE liner (X3, Stryker Orthopaedics, Mahwah, New Jersey). It was manufactured using a cycle of 30 kGy of gamma irradiation followed by annealing at 130°C for eight hours, repeated three times for a cumulative dose of 90 kGy. All patients had flat, neutral liners within a hemispherical shell (Trident, Stryker Orthopaedics) and all were matched with the same design of uncemented femoral component using a cobalt/chrome modular femoral head (Accolade, Stryker Orthopaedics). Whether a 36 mm or 40 mm liner was used in the current cohort was determined by the outer diameter of the acetabular component. A total of seven patients required an acetabular component with an outer diameter of 52 mm or 54 mm and had a 36 mm articulation with a resultant minimum thickness of the HXLPE liner of 5.9 mm; ten patients required an acetabular component with an outer diameter of 56 mm or 58 mm and had a 40 mm articulation with a resultant minimum thickness of the HXLPE liner of 5.8 mm; and two patients required an acetabular component with an outer diameter of 60 mm or 62 mm and had a 40 mm articulation with a resultant minimum thickness of the HXLPE liner of 7.4 mm. No patients required an acetabular component with an outer diameter > 62 mm.
Supine RSA examinations were undertaken within the first post-operative week and at six months, one, two and five years post-operatively. Ceiling-mounted and mobile radiographic tubes were used simultaneously to obtain exposures of the hip with a calibration cage (Number 43; RSA Biomedical, Umeå, Sweden). Penetration of the femoral head into the acetabular component was measured using UmRSA software (v6.0; RSA Biomedical). The outer ellipse and opening of the acetabular component were used to represent the acetabular segment for both cohorts in the RSA software. The maximum condition number and rigid body error accepted for each reference segment were 50 mm and 0.35 mm respectively.
The penetration of the femoral head was calculated in the medial, proximal and anterior axes. The 2D penetration was calculated as the vectorial sum of medial and proximal migrations and the 3D penetration was calculated as the vectorial sum of medial, proximal and anterior migrations. The immediate post-operative radiographs provided a baseline for calculation of the 'bedding-in' migration of the femoral head at one year. The slope of the regression line for the penetration recorded for each individual between one and five years was assumed to represent wear of the liner.
There were two patients who did not have post-operative RSA examinations within the first week and two others did not have RSA examinations at five years. Therefore, 15 hips (four with a 36 mm and 11 with a 40 mm articulation) were included in the study. The median age of the 12 men and three women was 64 years (interquartile range (IQR) 60 to 69); their median body mass index (BMI) was 28 (IQR 26 to 31) ( Table I ). The median diameter of the acetabular component was 56 mm (IQR 52 to 62); its median inclination was 47º (IQR 42º to 48º). Clinical outcome was assessed using the Oxford Hip Score (OHS), 25 which was recorded pre-operatively and at one and two years post-operatively. Statistical analysis. The data analysis was performed using SAS software (version 9.4 of the SAS System for Windows, SAS Institute Inc., Cary, North Carolina). A one-sided test of non-inferiority was considered the most appropriate statistical test to determine if the wear of the larger articulations was no greater than with 32 mm articulations. We previously reported that the median rate of proximal wear between one and two years for the 32 mm cohort was 0.02 mm/year (IQR -0.04 to 0.07). 23 Hence, a noninferiority margin of 0.03 mm was chosen, as an additional rate of wear of 0.03 mm/year would result in a clinically relevant rate of 0.05 mm/year, below which osteolysis is very rarely seen. 26 Therefore, the wear of the cohort with the larger articulation was not significantly greater than the cohort with a 32 mm articulation if the non-inferiority was supported (p < 0.05). Non-inferiority was supported if the 90% lower confidence limit of the pooled difference between means did not exceed the lower bound of -0.03. A post hoc power analysis was undertaken. Using the sample sizes of 15 and 18 for the large and 32 mm articulation cohorts respectively, and a difference between means of 0.01 with a standard deviation of 0.02, indicated that the study had 99% power to detect non-inferiority of the larger articulations relative to the 32 mm articulations with a threshold of -0.03 and an α = 0.05.
Results
No patients required revision or further surgery two years post-operatively. The median OHS improved from 24 (IQR 19 to 27) pre-operatively to 47 (IQR 43 to 48) at one year and 45 (IQR 40 to 48) at two years post-operatively. There were no differences in the mean OHS between the current cohort and the control cohort with 32 mm articulations (Table II) .
The median proximal penetration of the femoral head in the larger articulations between one week and five years was -0.016 mm (IQR -0.104 to 0.089) ( Table III) . The median proximal penetration at one year in the larger articulations, interpreted as 'bedding-in', was 0.022 mm (IQR -0.050 to 0.091). The median rate of proximal wear five years post-operatively was less than that at two years for each cohort and had less variability (Figs 1 and 2) . The median rate of proximal wear between one and five years was -0.004 mm/year (IQR -0.021 to 0.022) which was not statistically significantly greater than the median rate of proximal wear of the 32 mm articulation cohort, 0.003 mm/year (IQR -0.029 to 0.010) (p = 0.002) (Fig. 2 , Table III ). The medial, 2D and 3D rates of wear in the large articulations between one and five years were also not significantly greater than in the 32 mm cohort (p < 0.05, Table III ).
Discussion
The introduction of HXLPE in THA has significantly reduced polyethylene wear. 14 This has encouraged the use of larger articulations, which have been shown to reduce the rates of early dislocation. 4, 6 Registry data have reported widespread acceptance of HXLPE, improved clinical results and increased the use of femoral heads with a diameter of > 36 mm in primary THA. 1 However, the effect of larger articulations with relatively thin HXLPE liners on in vivo wear is unknown. Metal-backed acetabular components have been designed to be used in conjunction with various combinations of thickness of liner and size of fem- oral head to allow surgeons to select an implant appropriate for the individual patient. Historically the minimum thickness recommended for UHMWPE was 8 mm. 27 Catastrophic failures have been observed in UHMWPE liners with a minimum thickness of < 5 mm, 28 and some designs of HXLPE are vulnerable to rim cracking when positioned incorrectly. 29 In vitro studies of the X3 HXLPE liner have reported larger gravimetric wear with increasing sizes of head 18 and increased rates of wear with thinner liners. 19 A recent systematic search of RSA wear studies of HXLPE 30 found only one study which reported the rate of wear of a > 36 mm articulation. 31 In this report at three years, the median rate of proximal wear for the Longevity HXLPE (Zimmer, Warsaw, Indiana) liner used with 36 mm articulations was 0.000 mm/year, compared with 0.026 mm/year for 28 mm articulations. 31 Our in vivo results showed no statistically significant increase in the wear of the X3 liner between one and five years with larger articulations. Importantly, the median rates of proximal wear reported for both the larger and 32 mm cohorts were very low, < 0.005 mm/year. These rates are similar to those reported in the only other RSA study of X3 liners, by Gascoyne et al 32 who found a median rate of proximal wear of 0.001 mm/year used mostly with 32 mm femoral heads. There are only two in vivo wear studies of X3 liners used with larger 36 mm articulations. 33, 34 Sayeed et al 33 reported a mean 2D rate of wear of 0.0004 mm/year at two years for 26 primary THAs with a mean thickness of polythene of 3.8 mm, while Selvarajah et al 34 reported a much higher mean 2D rate of wear between one and five years postoperatively of 0.109 mm/year for 36 mm articulations. A rate of wear of 0.109 mm/year would mean that a high percentage of these hips were at risk of developing osteolysis. 26, 34 This report is concerning for surgeons using X3 liners with large articulations, which have also been found to increase the rate of wear of electron beam-irradiated and melted HXLPE in a large cohort study. 35 However, both of these studies (Selvarajah et al 34 and Bragdon et al 35 ) were limited by the use of measurements made from plain radiographs and highlight the importance of using a more sensitive technique such as RSA as used in our study.
The rate of wear decreased for both cohorts at five-year follow-up compared with that at two years (Figs 1 and 2 ). This decrease is consistent with three other RSA studies that have measured the wear of HXLPE at longer followup. 30 No individual in our larger or 32 mm cohorts had a rate of proximal or 2D wear > 0.045 mm/year at five years. This is below the historical threshold rate of wear of 0.05 mm/year associated with osteolysis in patients with older UHMWPE liners. 26 The rate of wear threshold of HXLPE liners is currently unknown and will require long-term clinical studies. The very low wear reported in our study is encouraging for future clinical use of larger articulations but it should be noted that the same linear rate of wear in larger articulations will result in a larger volume of wear. 36 There are also some recent concerns regarding the potential for increased corrosion and release of metal at the headneck taper junction of larger articulations. 36 However, the size of the femoral head has yet to be shown to effect the incidence of adverse local tissue reactions in metal on polyethylene articulations. 36 The main limitation of our study is that it is a comparison of two prospective cohorts recruited at different times. Specifically, rates of wear of the relatively new X3 HXLPE liner were investigated initially in THAs with a standard 32 mm articulation. After a low rate of early wear was established in this cohort, THAs with larger articulations were undertaken by the same surgeon in a similar cohort of patients, enabling the determination of wear in larger articulations. A second limitation is the small number of patients in each cohort, which is common to most RSA studies. However, a post hoc power analysis confirmed the adequacy of the sample sizes used in the comparison at five years. The same power analysis at two years revealed inadequate power (44%) due to the increased variability of the rates of wear in both cohorts. A third limitation is the use of the ellipse as the acetabular reference segment in the RSA results presented for both cohorts. The results of the 32 mm articulation control group previously reported 23, 24 used a combination of tantalum markers placed in the outer rim of the liner and the ellipse of the metal shell as the acetabular reference segment. Although this segment did not influence the accuracy of RSA measurements of wear in a phantom study, 22 the combined method has been shown to have the greatest precision clinically. 37, 38 This method could not be used in the current study because beads implanted in the periphery of the liner, irrespective of whether they received a 32 mm, 36 mm or 40 mm articulation, were commonly occluded by the larger femoral heads.
In conclusion, larger articulations did not significantly increase the mean rate of proximal, medial, 2D or 3D wear between one and five years post-operatively when using an X3 HXLPE liner when compared with a previous study of 32 mm articulations. This bodes well for the continued use of larger articulations, particularly in those patients, such as the elderly, in whom a decreased risk of dislocation is a priority. However, the use of larger articulations requires continued monitoring to determine whether the early low rates of wear continue in the long-term.
Take home message:
The wear of XLPE was not increased at five years when used with larger articulations which are being used more frequently to decrease the risk of dislocation.
